Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: U.S. Physical Therapy Inc., 3 years.
U.S. Physical Therapy Inc.
Director
RTX Corporation
Director
Solventum Corporation
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
U.S. Physical Therapy Inc. May 19, 202694.0%
-
Solventum Corporation May 15, 202681.0%
-
RTX Corporation April 30, 202698.8%
-
U.S. Physical Therapy Inc. May 20, 202591.4%
-
RTX Corporation May 1, 202599.4%
-
U.S. Physical Therapy Inc. May 21, 202489.4%
-
RTX Corporation May 2, 202498.8%
-
U.S. Physical Therapy Inc. May 16, 202390.8%
-
RTX Corporation May 2, 202398.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 19, 2026 | U.S. Physical Therapy Inc. | Grant or award | +2,306 | $61.61 | $142,073 |
| Apr 30, 2026 | Solventum Corporation | Option exercise | +3,403 | — | — |
| Mar 27, 2026 | Solventum Corporation | Option exercise | +1,980 | — | — |
| May 20, 2025 | U.S. Physical Therapy Inc. | Grant or award | +1,882 | — | — |
| May 13, 2025 | Solventum Corporation | Option exercise | +3,564 | — | — |
| Nov 12, 2024 | U.S. Physical Therapy Inc. | Open-market sale | −2,000 | $92.95 | $185,900 |
| May 20, 2024 | U.S. Physical Therapy Inc. | Grant or award | +1,424 | — | — |
| May 16, 2023 | U.S. Physical Therapy Inc. | Grant or award | +1,600 | — | — |
| Mar 15, 2023 | U.S. Physical Therapy Inc. | Open-market sale | −5,000 | $92.50 | $462,500 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.